1-4 of 4
Andrew J. Ullmann
Close
Sort by
Journal Articles

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

Ralf G. Meyer, Cedrik M. Britten, Daniela Wehler, Klaus Bender, Georg Hess, Abdo Konur, Udo F. Hartwig, Thomas C. Wehler, Andrew J. Ullmann, Chiara Gentilini, Lutz Uharek, Christoph Huber, Karin Kolbe, Wolfgang Herr
Journal: Blood
Blood (2006) 109 (1): 374–382.
https://doi.org/10.1182/blood-2006-03-005769
Published: 2006
Journal Articles

Early Cessation of a Vancomycin-Resistant Enterococci (VRE) Outbreak in a Hematology-Oncology Department after Implementation of an Enhanced Infection Control Intervention. A Single Center Experience.

Andrew J. Ullmann, MD, Thomas Fischer, MD, Bernd Jansen, MD, PhD, Christoph Huber, MD
Journal: Blood
Blood (2004) 104 (11): 2209.
https://doi.org/10.1182/blood.V104.11.2209.2209
Published: 2004
Journal Articles

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

Clinical Trials & Observations
Oliver A. Cornely, Andrew J. Ullmann, Meinolf Karthaus
Journal: Blood
Blood (2003) 101 (9): 3365–3372.
https://doi.org/10.1182/blood-2002-05-1356
Published: 2003
Journal Articles

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients

Clinical Trials & Observations
Per Ljungman, Giorgio Lambertenghi Deliliers, Uwe Platzbecker, Susanne Matthes-Martin, Andrea Bacigalupo, Hermann Einsele, Johanna Ullmann, Maurizio Musso, Rudolf Trenschel, Patricia Ribaud, Martin Bornhäuser, Simone Cesaro, Bruce Crooks, Adrian Dekker, Nicole Gratecos, Thomas Klingebiel, Elena Tagliaferri, Andrew J. Ullmann, Pierre Wacker, Catherine Cordonnier
Journal: Blood
Blood (2001) 97 (2): 388–392.
https://doi.org/10.1182/blood.V97.2.388
Published: 2001